コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ding constituent disaccharides, by bacterial heparin lyases.
2 ulfated heparan sulfate that was digested by heparin lyases.
3 ated tetrasaccharide isolated from bacterial heparin lyase 1 digests of heparin that contains a Delta
5 tionated heparin, non-anticoagulant heparin, heparin lyases, and lung heparan sulfate potently block
7 s spectrometry (LC-MS) methods for profiling heparin lyase decomposition products have been shown.
8 eparin by its partial depolymerization using heparin lyase I (EC 4.2.2.7) in an attempt to prepare ol
9 enzymatic digestion of cell surface GAGs by heparin lyase I and heparin lyase III but not chondroiti
11 t solutions to remove lipids before applying heparin lyases I, II, and III on the tissue surfaces wit
14 the quantitative detection of heparosan with heparin lyase III and spectrophotometry that is safer an
15 of cell surface GAGs by heparin lyase I and heparin lyase III but not chondroitinase ABC resulted in
16 olysaccharide was sensitive to the action of heparin lyase III but resistant to hyaluronan lyase.
17 metry of the oligosaccharides obtained after heparin lyase III digestion of the polysaccharide indica
20 nalyze 3-O-sulfated HS oligosaccharides from heparin lyase III-digested HS from porcine intestinal mu
26 or- and integrin-dependent pathways, whereas heparin lyase-treated and beta1 integrin-null cells exhi
27 y induced the spreading of SMCs, whereas the heparin lyase treatment of PDGF-AA-stimulated cultures d
28 o used to examine substrate specificities of heparin lyases, which are enzymes used for depolymerizat
29 ulfate chains with nitrous acid or bacterial heparin lyases, which cut the chain at specific sequence